Venkatesh L Murthy1, Edward P Ficaro2,1, Jonathan B Moody3, Alexis Poitrasson-Rivière2, Tomoe Hagio2, Christopher Buckley4, Richard L Weinberg1, James R Corbett1,5. 1. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. 2. INVIA Medical Imaging Solutions, 3025 Boardwalk Street, Suite 200, Ann Arbor, MI, 48108, USA. 3. INVIA Medical Imaging Solutions, 3025 Boardwalk Street, Suite 200, Ann Arbor, MI, 48108, USA. jmoody@inviasolutions.com. 4. GE Pharmaceutical Diagnostics R&D, Amersham, UK. 5. Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: 18F-Flurpiridaz is a promising investigational radiotracer for PET myocardial perfusion imaging with favorable properties for quantification of myocardial blood flow (MBF). We sought to validate the incremental diagnostic value of absolute MBF quantification in a large multicenter trial against quantitative coronary angiography. METHODS: We retrospectively analyzed a subset of patients (N = 231) from the first phase 3 flurpiridaz trial (NCT01347710). Dynamic PET data at rest and pharmacologic stress were fit to a previously validated 2-tissue-compartment model. Absolute MBF and myocardial flow reserve (MFR) were compared with coronary artery disease severity quantified by invasive coronary angiography on a per-patient and per-vessel basis. RESULTS: Stress MBF per-vessel accurately identified obstructive disease (c-index 0.79) and progressively declined with increasing stenosis severity (2.35 ± 0.71 in patients without CAD; 1.92 ± 0.49 in non-obstructed territories of CAD patients; and 1.54 ± 0.50 in diseased territories, P < 0.05). MFR similarly declined with increasing stenosis severity (3.03 ± 0.94; 2.69 ± 0.95; and 2.33 ± 0.86, respectively, P < 0.05). In multivariable logistic regression modeling, stress MBF and MFR provided incremental diagnostic value beyond patient characteristics and relative perfusion analysis. CONCLUSIONS: Clinical myocardial blood flow measurement with 18F-flurpiridaz cardiac PET shows promise for routine application.
BACKGROUND: 18F-Flurpiridaz is a promising investigational radiotracer for PET myocardial perfusion imaging with favorable properties for quantification of myocardial blood flow (MBF). We sought to validate the incremental diagnostic value of absolute MBF quantification in a large multicenter trial against quantitative coronary angiography. METHODS: We retrospectively analyzed a subset of patients (N = 231) from the first phase 3 flurpiridaz trial (NCT01347710). Dynamic PET data at rest and pharmacologic stress were fit to a previously validated 2-tissue-compartment model. Absolute MBF and myocardial flow reserve (MFR) were compared with coronary artery disease severity quantified by invasive coronary angiography on a per-patient and per-vessel basis. RESULTS: Stress MBF per-vessel accurately identified obstructive disease (c-index 0.79) and progressively declined with increasing stenosis severity (2.35 ± 0.71 in patients without CAD; 1.92 ± 0.49 in non-obstructed territories of CAD patients; and 1.54 ± 0.50 in diseased territories, P < 0.05). MFR similarly declined with increasing stenosis severity (3.03 ± 0.94; 2.69 ± 0.95; and 2.33 ± 0.86, respectively, P < 0.05). In multivariable logistic regression modeling, stress MBF and MFR provided incremental diagnostic value beyond patient characteristics and relative perfusion analysis. CONCLUSIONS: Clinical myocardial blood flow measurement with 18F-flurpiridaz cardiac PET shows promise for routine application.
Authors: Michael Fiechter; Jelena R Ghadri; Cathérine Gebhard; Tobias A Fuchs; Aju P Pazhenkottil; Rene N Nkoulou; Bernhard A Herzog; Christophe A Wyss; Oliver Gaemperli; Philipp A Kaufmann Journal: J Nucl Med Date: 2012-06-29 Impact factor: 10.057
Authors: Jamshid Maddahi; Johannes Czernin; Joel Lazewatsky; Sung-Cheng Huang; Magnus Dahlbom; Heinrich Schelbert; Richard Sparks; Alexander Ehlgen; Paul Crane; Qi Zhu; Marybeth Devine; Michael Phelps Journal: J Nucl Med Date: 2011-08-17 Impact factor: 10.057
Authors: Hossam M Sherif; Stephan G Nekolla; Antti Saraste; Sybille Reder; Ming Yu; Simon Robinson; Markus Schwaiger Journal: J Nucl Med Date: 2011-04 Impact factor: 10.057
Authors: Nicolas J Guehl; Marc D Normandin; Dustin W Wooten; Guy Rozen; Arkadiusk Sitek; Jeremy Ruskin; Timothy M Shoup; Leon M Ptaszek; Georges El Fakhri; Nathaniel M Alpert Journal: Eur J Nucl Med Mol Imaging Date: 2017-04-01 Impact factor: 9.236
Authors: Sami A Kajander; Esa Joutsiniemi; Markku Saraste; Mikko Pietilä; Heikki Ukkonen; Antti Saraste; Hannu T Sipilä; Mika Teräs; Maija Mäki; Juhani Airaksinen; Jaakko Hartiala; Juhani Knuuti Journal: Circ Cardiovasc Imaging Date: 2011-09-16 Impact factor: 7.792
Authors: O Muzik; C Duvernoy; R S Beanlands; S Sawada; F Dayanikli; E R Wolfe; M Schwaiger Journal: J Am Coll Cardiol Date: 1998-03-01 Impact factor: 24.094
Authors: S G Nekolla; S Reder; A Saraste; T Higuchi; G Dzewas; A Preissel; M Huisman; T Poethko; T Schuster; M Yu; S Robinson; D Casebier; J Henke; H J Wester; M Schwaiger Journal: Circulation Date: 2009-04-20 Impact factor: 29.690
Authors: Daniel S Berman; Jamshid Maddahi; B K Tamarappoo; Johannes Czernin; Raymond Taillefer; James E Udelson; C Michael Gibson; Marybeth Devine; Joel Lazewatsky; Gajanan Bhat; Dana Washburn Journal: J Am Coll Cardiol Date: 2012-12-19 Impact factor: 24.094
Authors: René R S Packard; Sung-Cheng Huang; Magnus Dahlbom; Johannes Czernin; Jamshid Maddahi Journal: J Nucl Med Date: 2014-07-28 Impact factor: 10.057
Authors: Susan Bengs; Geoffrey I Warnock; Catherine Gebhard; Ahmed Haider; Angela Portmann; Nidaa Mikail; Alexia Rossi; Hazem Ahmed; Dominik Etter; Valerie Treyer; Livio Gisler; Stefanie K Pfister; Caitlin V M L Jie; Alexander Meisel; Claudia Keller; Steven H Liang; Roger Schibli; Linjing Mu; Ronny R Buechel; Philipp A Kaufmann; Simon M Ametamey Journal: J Nucl Cardiol Date: 2022-04-28 Impact factor: 5.952
Authors: Nidaa Mikail; Alexia Rossi; Susan Bengs; Ahmed Haider; Barbara E Stähli; Angela Portmann; Alessio Imperiale; Valerie Treyer; Alexander Meisel; Aju P Pazhenkottil; Michael Messerli; Vera Regitz-Zagrosek; Philipp A Kaufmann; Ronny R Buechel; Cathérine Gebhard Journal: Eur J Nucl Med Mol Imaging Date: 2022-08-17 Impact factor: 10.057
Authors: René R Sevag Packard; C David Cooke; Kenneth F Van Train; John R Votaw; James W Sayre; Joel L Lazewatsky; Kelly M Champagne; Cesare Orlandi; Ernest V Garcia; Jamshid Maddahi Journal: J Nucl Cardiol Date: 2020-09-07 Impact factor: 5.952